KRAS and Miyoshi myopathy: Considering the frequent presence of activating mutations in the KRAS proto-oncogene among MM and MGUS patients, with implications for disease prognosis [37], it is noteworthy that USP39 has been implicated in the development of KRAS-driven lung and colon cancers [38].